Borrowing from the latest in genetic and stem cell research, cosmetic companies and medical skin care developers are exploring the exciting possibilities of subdermal DNA repair and latent stem cell activation.

It is important to note at the outset that as of yet, none of the cosmetic products sold over the counter (OTC) have been tested by the Federal Food and Drug Administration (FDA) to verify their claims. However, in the case of the potential of DNA repairs from topical application, there is some precedent.

AGI Dermatics holds the patent on Dimericine, TN45 Liposome Lotion, which is currently undergoing FDA clinical trials. Dimericine’s active ingredients are enzymes that are engineered to mimic those already in the body, allowing skin to genetically repair itself after exposure to too many UV rays from the sun. However, the OTC cosmetic version of DNA repair being marketed by the same firm uses enzymes derived from sea plants suspended in a microsphere which is designed to be absorbed into the skin so that the plankton enzymes can act on DNA in much the same way as Dimericine. The medical application is under review in skin cancer treatment, so the FDA’s findings will hold interest across the board when considered alongside the cosmetic brand enzyme.

Telomerase is the active ingredient in the new stem cell creams. It is designed to inhibit cellular mutation and stimulate DNA stem cell growth in the skin. Another enzyme-driven cosmetic solution to younger skin, perhaps, but no testing is yet being done to gauge the efficacy of telomerase as a topical application.

To be sure you’re using safe, tested, clinical solutions in your skin care regimen, for now, it’s recommended that consumers use hydration which incorporates enzymes like Co-Enzyme Q10, and vitamins which have been shown to achieve subdermal results, like vitamin E.